Suchergebnisse - "D'Arena, Giovanni"

PubPharm (12)

1

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2019

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

2

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

3

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

4

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

enthalten in: Annals of hematology | 2018

von Musto, P. | Simeon, V. | Cascavilla, N. | +25

5

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia : impact of biological parameters on clinical outcome

enthalten in: Annals of hematology | 2014

von De Padua, L. | Laurenti, L. | Falcucci, P. | +9

6

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

enthalten in: Annals of hematology | 2013

von De Padua, L. | Laurenti, L. | Falcucci, P. | +9

7

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

enthalten in: Annals of hematology | 2013

von De Padua, L. | Laurenti, L. | Falcucci, P. | +9

8

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

enthalten in: Annals of hematology | 2013

von De Padua, L. | Laurenti, L. | Falcucci, P. | +9

9

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia : influence of biological parameters on the clinical outcome

enthalten in: Annals of hematology | 2011

von Laurenti, L. | De Padua, L. | Tarnani, M. | +11

10

Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome

enthalten in: Annals of hematology | 2010

von Laurenti, L. | De Padua, L. | Tarnani, M. | +11